Whitening composition containing endothelin antagonist as well as preparation method and application thereof
A technology of endothelin antagonist and composition, which is applied in the direction of medical preparations containing active ingredients, skin care preparations, pharmaceutical formulations, etc., which can solve the problems of high transdermal absorption and no problem, and achieve transdermal absorption Good, high safety, high bioavailability effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0028] The preparation method among the present invention, comprises the steps:
[0029] 1) mixing the complex phospholipid and emulsifier, stirring and heating until the solid material is completely melted, and cooling to room temperature to obtain an oil phase mixture;
[0030] 2) mixing the endothelin antagonist, polyhydric alcohol and water, and stirring evenly to obtain a water phase mixture;
[0031] 3) Add the oil phase mixture in step 1) to the water phase mixture in step 2), then add whitening agent and antioxidant, and then homogenize at a high speed to obtain a micro-emulsion;
[0032] 4) The micro-emulsion in step 3) is subjected to multiple times of high-pressure 300-1200 bar homogenization or high-speed micro-jet treatment to obtain a nano-emulsion with a particle size of 10-500 nm.
Embodiment 1
[0034] The whitening composition containing endothelin antagonist of the present embodiment consists of the following components in parts by weight:
[0035] Endothelin antagonist: 0.50 parts of emblica fruit extract, 0.50 parts of hydrolyzed conchiolin; whitening agent: 1.00 parts of Scutellaria baicalensis root extract, 5.00 parts of licorice root extract, 10.00 parts of Ascophyllum nodosum extract; antioxidant: Carnosine 1.00 parts; complex phospholipids: lecithin 2.00 parts, hydrogenated lecithin 3.00 parts; emulsifier: PEG-75 stearate 2.00 parts, polyglycerol-10 pentastearate 3.00 parts; polyol: butylene glycol 10.00 parts 3.00 parts of 1,2-hexanediol; 89.00 parts of water.
Embodiment 2
[0037] The whitening composition containing endothelin antagonist of the present embodiment consists of the following components in parts by weight:
[0038] Endothelin antagonist: emblica fruit extract 8.00 parts, undecylenoyl phenylalanine 2.00 parts; whitening agent: phenylethyl resorcinol 0.10 parts; antioxidant: edelweiss flower extract 5.00 parts, ginkgo biloba Leaf extract 5.00 parts; complex phospholipids: lysolecithin 7.00 parts, dipalmitoylphosphatidylcholine 3.00 parts; emulsifier: polysorbate-60 1.00 parts; polyols: butylene glycol 10.00 parts, 1,3- 10.00 parts of propylene glycol; 48.90 parts of water.
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com